High levels of PYK2 were associated with poor survival and metastasis in HCC via activation of the PI3K/AKT pathway by PYK2-dependent phosphorylation of AKT, which was reversed by the PI3K/AKT inhibitor LY294002 (21). Here, PTK2B is linked to hepatocellular carcinoma.